Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MedReps.com Report Shows Biotech Workers Earn the Most in Medical Sales
CP Wire
Thursday, June 20, 2013 - 12:56pm
tags:
devices, biotech
GSK links with French venture firm to target rare diseases
Reuters
Thursday, June 20, 2013 - 12:35pm
tags:
GSK, Kurma Life Sciences Partners, venture funds
Nearly 7-in-10 adults take a prescription drug, study finds
Drugstore News
Thursday, June 20, 2013 - 12:34pm
tags:
prescription data
Off-Label Marketing Puts Novartis in Hot Water
Courthouse News
Thursday, June 20, 2013 - 12:33pm
tags:
off-label, Novartis, whistleblower lawsuits, Elidel
10 Most-Shorted Biotech Stocks of 2013
TheStreet.com
Thursday, June 20, 2013 - 12:24pm
tags:
InterMune, Hyperion, Arena Pharmaceuticals, Sunesis, Synta Pharmaceuticals, Ziopharm, MannKind, Dendreon, Spectrum Pharmaceuticals, Sarepta Therapeutics
Celgene's candidates for non-Hodgkin's lymphomas show positive results
The Fly on the Wall
Thursday, June 20, 2013 - 12:19pm
tags:
Celgene, non-Hodgkin's lymphoma, Revlimid, rituximab
Abbott hepatitis C genotyping test approved by FDA
Yahoo/Fly on the Wall
Thursday, June 20, 2013 - 12:17pm
tags:
Abbott Laboratories, genotyping text, hepatitis C, FDA
What to Expect From Arena Pharmaceuticals' Launch of Belviq
Motley Fool
Thursday, June 20, 2013 - 11:05am
tags:
drug launches, obesity, Arena Pharmaceuticals, Belviq
Durect says FDA is reviewing long-lasting surgery pain drug Posidur, with decision due in Feb.
Yahoo/AP
Thursday, June 20, 2013 - 11:03am
tags:
Durect, FDA, Posidur, post-surgical pain
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Seeking Alpha
Thursday, June 20, 2013 - 11:00am
tags:
Eli Lilly, patents, empagliflozin, dulaglutide, ixekizumab, ramucirumab
Obesity Sector Gets New Shoes
Seeking Alpha
Thursday, June 20, 2013 - 7:48am
tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen, Contrave, Belviq, Qsymia
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thursday, June 20, 2013 - 7:46am
tags:
Infinity Pharmaceuticals, JNJ, Pharmacyclics, Gilead, non-Hodgkin's lymphoma, ibrutinib, Idelalisib, IPI-145
Glaxo Gets Offer for Thrombosis Drugs
Yahoo/Zacks
Thursday, June 20, 2013 - 7:36am
tags:
GSK, thrombosis, M&A, Arixtra, Fraxiparine, Aspen Pharmacare
Pfizer Share Swap for Animal Health Stake Hits Top Limit
Bloomberg
Thursday, June 20, 2013 - 7:33am
tags:
Pfizer, Zoetis, spinoff, animal health
Biogen's impressive Tecfidera launch hits reimbursement, supply snags
Fierce Pharma
Wednesday, June 19, 2013 - 4:07pm
tags:
Biogen Idec, Tecfidera, reimbursement, MS, multiple sclerosis, drug launches
Investors Applaud Vivus' Erectile Dysfunction Drug
FOX Business
Wednesday, June 19, 2013 - 4:05pm
tags:
investors, Vivus, erectile dysfunction, Stendra
Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
Yahoo/Fly on the Wall
Wednesday, June 19, 2013 - 4:03pm
tags:
Eli Lilly, Elanco
Nektar Therapeutics Gains on Trial of New Painkiller
Bloomberg
Wednesday, June 19, 2013 - 4:01pm
tags:
Nektar, NKTR-181, abuse-resistant painkillers
3 Biotechs With Strong Momentum - Can They Keep It Up?
Seeking Alpha
Wednesday, June 19, 2013 - 3:57pm
tags:
Acadia, Celldex, Keryx
Keryx Patents Seen Overcoming Generic Competition
Investors.com
Wednesday, June 19, 2013 - 3:55pm
tags:
Keryx, patents, generics, chronic kidney disease, Zerenex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.